French MedTech developer Sanofi has completed its acquisition of Vigil Neuroscience, Inc., aiming to enhance its neurology pipeline with a new investigational medicine for Alzheimer’s…
View More Sanofi Completes Acquisition of Vigil Neuroscience to Enhance Alzheimer’s Treatment Pipeline